Aemetis (NASDAQ:AMTX) Announces Quarterly Earnings Results, Beats Estimates By $0.18 EPS

Aemetis (NASDAQ:AMTX) posted its quarterly earnings results on Thursday. The specialty chemicals company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.18, FiscalAI reports. The business had revenue of $88.15 million during the quarter, compared to analysts’ expectations of $74.20 million.

Here are the key takeaways from Aemetis’ conference call:

• Third-quarter results improved sharply: revenue rose 49% year over year to $88.2 million, net income was $5.2 million, and Adjusted EBITDA reached $24.8 million, versus a loss in both measures a year earlier. Results included $24.7 million in 45Z tax-credit revenue, including an $11 million catch-up adjustment, so reported performance was partly driven by credits.
• Aemetis said seven dairy RNG pathways averaging a carbon-intensity score of negative 380 are approved, with six more pending, supporting greater LCFS credit generation. The company also reported 14 operating digesters and said production has exceeded its forecasts, though further growth depends in part on new pathway approvals and financing.
• The Keyes ethanol plant’s MVR project is expected by management to add about $32 million in annual cash flow through lower natural-gas use and higher-value credits. Construction is progressing, but completion is targeted for the first half of 2027 and management expects most financial benefits in the second half, subject to commissioning.
• Quarter-end cash was $3.4 million after $20.2 million of quarterly capital investment; the company also received $22.4 million from selling 45Z credits. A biogas preferred-unit redemption date was extended to December 31, 2026, highlighting ongoing funding and liquidity considerations.
• India biodiesel sales rebounded to $7.3 million as deliveries resumed under a $17 million allocation, and the company expects export approvals for Europe in the fourth quarter. Management cited potential access to its 80-million-gallon capacity, but noted practical supply-chain limits and did not expect long-term offtake contracts.

Aemetis Price Performance

NASDAQ:AMTX opened at $1.62 on Friday. The stock has a market cap of $116.92 million, a P/E ratio of -2.89 and a beta of 1.87. Aemetis has a one year low of $1.11 and a one year high of $3.80. The company has a fifty day moving average price of $1.66 and a 200 day moving average price of $1.94.

Key Headlines Impacting Aemetis

Here are the key news stories impacting Aemetis this week:

• Positive Sentiment: Q3 revenue rose 49% year over year to $88.2 million. Aemetis reported $5.2 million in net income, $20.9 million in operating income and $24.8 million in adjusted EBITDA. The company’s reported loss of $0.02 per share also beat the $0.20 loss analysts expected. Aemetis Q3 financial results
• Positive Sentiment: Aemetis said Section 45Z production tax credit income was $24.7 million for the quarter, including an approximately $11 million cumulative adjustment after an updated federal emissions model. A separate report says the company expects its MVR project to contribute $32 million in annual cash flow in 2027 as 45Z values reset higher, supporting its future cash-flow outlook. MVR and 45Z outlook
• Positive Sentiment: Biogas RNG sales volume increased 39% year over year to 158,200 MMBtu, and two new dairy digesters began operating in October, expanding the network to 14 digesters serving 17 dairies. Aemetis Q3 financial results
• Neutral Sentiment: Despite the earnings beat and improved outlook, AMTX is trading lower. The available reports offer no clear explanation for the share-price weakness, so investors may be weighing execution and the timing of future project cash flows against the strong quarterly results.

Analyst Ratings Changes

AMTX has been the topic of several analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a research note on Thursday, October 15th. Wall Street Zen upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a report on Saturday, August 22nd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Aemetis currently has an average rating of “Hold” and an average target price of $11.88.

About Aemetis

Aemetis, Inc is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies.

The company’s California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.